AC Immune (ACIU) EBIAT: 2015-2025
Historic EBIAT for AC Immune (ACIU) over the last 10 years, with Sep 2025 value amounting to -$19.8 million.
- AC Immune's EBIAT fell 412.11% to -$19.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$94.5 million, marking a year-over-year decrease of 198.11%. This contributed to the annual value of -$58.1 million for FY2024, which is 4.94% up from last year.
- Latest data reveals that AC Immune reported EBIAT of -$19.8 million as of Q3 2025, which was up 27.94% from -$27.5 million recorded in Q2 2025.
- In the past 5 years, AC Immune's EBIAT ranged from a high of $10.0 million in Q4 2023 and a low of -$27.6 million during Q2 2024.
- For the 3-year period, AC Immune's EBIAT averaged around -$16.5 million, with its median value being -$19.8 million (2025).
- As far as peak fluctuations go, AC Immune's EBIAT surged by 151.36% in 2023, and later crashed by 412.11% in 2025.
- Over the past 5 years, AC Immune's EBIAT (Quarterly) stood at -$23.1 million in 2021, then climbed by 15.65% to -$19.5 million in 2022, then skyrocketed by 151.36% to $10.0 million in 2023, then tumbled by 359.91% to -$26.0 million in 2024, then tumbled by 412.11% to -$19.8 million in 2025.
- Its last three reported values are -$19.8 million in Q3 2025, -$27.5 million for Q2 2025, and -$21.2 million during Q1 2025.